The US health care system is increasingly focusing on value as a basis for reimbursement of pharmacotherapies and devices, and as a result the use of “value frameworks” for measuring and comparing treatment value has grown in recent years. However, the
Read More...
Read the complete post at http://healthaffairs.org/blog/2017/04/12/value-frameworks-for-rare-diseases-should-they-be-different/
Posted
Apr 12 2017, 07:12 AM
by
Health Affairs BlogHealth Affairs Blog